1. Home
  2. BMM vs EMBC Comparison

BMM vs EMBC Comparison

Compare BMM & EMBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Blue Moon Metals Inc. Common Shares

BMM

Blue Moon Metals Inc. Common Shares

N/A

Current Price

$2.50

Market Cap

341.3M

Sector

N/A

ML Signal

N/A

Logo Embecta Corp.

EMBC

Embecta Corp.

N/A

Current Price

$6.02

Market Cap

354.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BMM
EMBC
Founded
2007
1924
Country
Canada
United States
Employees
68
N/A
Industry
Medical/Dental Instruments
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
341.3M
354.1M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
BMM
EMBC
Price
$2.50
$6.02
Analyst Decision
Buy
Hold
Analyst Count
2
4
Target Price
★ $9.02
$4.00
AVG Volume (30 Days)
533.9K
★ 719.9K
Earning Date
11-23-2026
11-24-2026
Dividend Yield
N/A
★ 0.65%
EPS Growth
N/A
★ 20.90
EPS
N/A
★ 1.03
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$5.59
P/E Ratio
★ N/A
$6.00
Revenue Growth
N/A
N/A
52 Week Low
$2.71
$2.77
52 Week High
$8.63
$14.78

Technical Indicators

Market Signals
Indicator
BMM
EMBC
Relative Strength Index (RSI) 27.08 43.28
Support Level N/A $5.64
Resistance Level $6.58 $6.85
Average True Range (ATR) 0.36 0.36
MACD -0.03 -0.07
Stochastic Oscillator 6.08 19.31

Price Performance

Historical Comparison
BMM
EMBC

About BMM Blue Moon Metals Inc. Common Shares

Blue Moon Metals Inc is a Canadian exploration stage company focused on the exploration and development of mineral resource properties. The company is advancing its Blue Moon polymetallic deposit which contains zinc, gold, silver, and copper. The projects of the company include the Nussir copper-gold-silver property in Norway (the "Nussir Property"), the Blue Moon zinc-copper-gold-silver property in California, USA (the "Blue Moon Property"), the NSG copper-zinc-gold-silver property in Norway (the "NSG Property") the Springer tungsten-molybdenum project in the Nevada, USA (the "Springer Property") and the Apex germanium-gallium-copper project in Utah, USA (the "APEX Property").

About EMBC Embecta Corp.

Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.

Share on Social Networks: